Page last updated: 2024-10-23

berberine and Astrocytoma

berberine has been researched along with Astrocytoma in 1 studies

Astrocytoma: Neoplasms of the brain and spinal cord derived from glial cells which vary from histologically benign forms to highly anaplastic and malignant tumors. Fibrillary astrocytomas are the most common type and may be classified in order of increasing malignancy (grades I through IV). In the first two decades of life, astrocytomas tend to originate in the cerebellar hemispheres; in adults, they most frequently arise in the cerebrum and frequently undergo malignant transformation. (From Devita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2013-7; Holland et al., Cancer Medicine, 3d ed, p1082)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, DY1
Yeh, CC1
Lee, JH1
Hung, CF1
Chung, JG1

Other Studies

1 other study available for berberine and Astrocytoma

ArticleYear
Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
    Neurochemical research, 2002, Volume: 27, Issue:9

    Topics: Arylamine N-Acetyltransferase; Astrocytoma; Base Sequence; Berberine; Brain Neoplasms; DNA Adducts;

2002